23andMe, Genentech signs $60 mn deal for research on Parkinson’s cure

January 8, 2015 11:16 PM

16 0

Genetic testing company 23andMe Inc and Genentech has teamed up to work in direction of finding new and effective treatment methods for people with Parkinson’s disease.

The companies on Tuesday entered into a USD 60 million deal over generating genome sequencing data for the patients of Parkinson’s.

Read more

To category page